UNSPSC 51312902: Etoloxamine

This classification denotes a histamine-1 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NEZ417265P. European Medicines Agency schedules Etoloxamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07329MIG. Etoloxamine generally arises in the molecular formula C19H25NO.

UNSPSC 51312902 Etoloxamine, a Commodity code, represents pharmaceutical products and overdose-reversal agents that state and local governments procure for public health and emergency response support. The code covers active pharmaceutical ingredients and formulated medications used in community health initiatives, opioid crisis response, and emergency medical services. State and local issuing bodies soliciting under this code include county health departments and public health agencies managing naloxone and drug-deactivation system procurement for community health building distribution and emergency response networks. The work involves competitive bidding for pharmaceutical supplies with strict compliance requirements around drug-free workplace certification, E-Verify employment verification, appropriate insurance coverage (workers' compensation, commercial general liability, and professional liability), and federal regulatory adherence when FEMA or other federal funding is involved.

Seminole County, Florida represents the primary recent activity under the code. Seminole County Community Health Department issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug-deactivation systems annually with a response deadline of July 26, 2023, through electronic submission via the county's e-Procurement Portal. The contract specified quarterly deliveries to the Seminole County Community Health Building at 520 W. Lake Mary Blvd, Sanford, Florida, with vendors responsible for all shipping and delivery costs. The initial term runs two years with a one-year renewal option, and pricing is fixed-fee. The procurement did not specify set-aside designations for disadvantaged enterprises. Beyond this single recent opportunity, the source documents no additional state or local activity under the code.